Table 2.
Antihypertensive Therapy and Body Mass Index at Baseline and 1 Year After Initiation of CPAP
| Antihypertensive agent use, no (%) | Controlled Hypertension |
Resistant Hypertension |
||
|---|---|---|---|---|
| Baseline | 12 months | Baseline | 12 months | |
| ACE inhibitor | 25 (44) | 24 (43) | 37 (88) | 34 (81) |
| Diuretic | 30 (53) | 28 (50) | 33 (78) | 30 (71) |
| β blocker | 29 (52) | 30 (53) | 27 (64) | 25 (59) |
| Calcium-channel blocker | 10 (18) | 8 (14) | 18 (43) | 13 (31)a |
| Other | 3 (5) | 2 (3) | 9 (21) | 4 (9)a |
| Antihypertensive drugsb | 1.5 ± 0.5 | 1.4 ± 0.6 | 3.4 ± 0.8 | 2.8 ± 0.05 |
| BMI, kg/m2 | 37.7 ± 7.1 | 36.2 ± 9.1 | 38.5 ± 10.2 | 37.8 ± 9.9 |
Data are presented as mean ± SD, unless otherwise indicated. CPAP refers to continuous positive airway pressure; ACE, angiotensin converting enzyme inhibitor; BMI, body mass index.
a
p < 0.05;
b
Antihypertensive drugs refers to the number of drugs used per person.